Alcohol consumption appears to protect against non-alcoholic fatty liver disease

被引:97
|
作者
Moriya, A.
Iwasaki, Y. [1 ]
Ohguchi, S. [2 ]
Kayashima, E. [2 ]
Mitsumune, T. [2 ]
Taniguchi, H.
Ikeda, F.
Shiratori, Y. [3 ]
Yamamoto, K.
机构
[1] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol & Hepatol, Kita Ku, Okayama 7008558, Japan
[2] Junpukai Hlth Maintenance Ctr, Okayama, Japan
[3] Miyamoto Hosp, Dept Med, Ibaraki, Japan
关键词
CORONARY-HEART-DISEASE; METABOLIC SYNDROME; INSULIN SENSITIVITY; PLASMA ADIPONECTIN; DRINKING; RISK; MEN; LIGHT; MICE; STEATOHEPATITIS;
D O I
10.1111/j.1365-2036.2010.04520.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P>Background Moderate alcohol consumption may have certain beneficial effects against non-alcoholic fatty liver disease, which is associated with metabolic syndrome. Aim To determine the association between drinking pattern and fatty liver in Japanese men and women. Methods A cross-sectional study was performed with health checkup data including information concerning alcohol consumption and ultrasonographic assessment of fatty liver. Results We analysed 4957 men and 2155 women without reported liver diseases (median age, 49 years). In men, 40% of nondrinkers and 28% of drinkers had fatty liver. Alcohol consumption was inversely associated with fatty liver (adjusted odds ratio, 0.54; 95% confidence interval, 0.46-0.63). The prevalence of fatty liver in each category of drinking frequency was 38% (1-3 days/week), 29% (4-6 days/week), and 24% (daily drinking); there was a significant inverse correlation between drinking frequency and the prevalence of fatty liver (P < 0.001). In women, 16% of nondrinkers and 10% of drinkers had fatty liver. Drinking less than 20 g on 1-3 days/week was associated with low prevalence of fatty liver (adjusted odds ratio, 0.47; 95% confidence interval, 0.23-0.96). Conclusions Alcohol consumption appears to protect against non-alcoholic fatty liver disease.
引用
收藏
页码:378 / 388
页数:11
相关论文
共 50 条
  • [31] Non-alcoholic fatty liver disease
    Bjornsson, Einar
    Angulo, Paul
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2007, 42 (09) : 1023 - 1030
  • [32] Non-alcoholic fatty liver disease
    Cua, IHY
    George, J
    [J]. HOSPITAL MEDICINE, 2005, 66 (02): : 106 - 111
  • [33] Non-alcoholic fatty Liver disease
    Calderaro, Julien
    Zafrani, Elie Serge
    [J]. ANNALES DE PATHOLOGIE, 2010, 30 (06) : 413 - 420
  • [34] Non-alcoholic fatty liver disease
    Adams, LA
    Angulo, P
    [J]. LIVER DISEASES: ADVANCES IN TREATMENT AND PREVENTION: IN HONOUR OF HANS POPPER'S 100TH BIRTHDAY, 2004, 137 : 250 - 270
  • [35] Non-alcoholic fatty liver disease
    Farrell, Geoffrey C.
    Wardell, Rebecca
    Teoh, Narci
    Chitturi, Shiv
    [J]. INTERNAL MEDICINE JOURNAL, 2019, 49 (05) : 681 - 683
  • [36] Non-alcoholic fatty liver disease
    Sattar, Naveed
    Forrest, Ewan
    Preiss, David
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
  • [37] Non-alcoholic fatty liver disease
    Li, Wenhao
    Alazawi, William
    [J]. CLINICAL MEDICINE, 2020, 20 (05) : 509 - 512
  • [38] Non-Alcoholic Fatty Liver Disease
    Engin, Atilla
    [J]. OBESITY AND LIPOTOXICITY, 2017, 960 : 443 - 467
  • [39] Non-alcoholic fatty liver disease
    Brent A. Neuschwander-Tetri
    [J]. BMC Medicine, 15
  • [40] Non-alcoholic fatty liver disease
    Alba, LM
    Lindor, K
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (08) : 977 - 986